• Issue

    Clinical and Translational Discovery: Volume 4, Issue 1

    February 2024

ISSUE INFORMATION

Open Access

Issue Information

  • First Published: 01 February 2024

SHORT COMMUNICATION

Open Access

Financial relationships between board-certified neurologists and the pharmaceutical industry in Japan

  • First Published: 22 January 2024
Financial relationships between board-certified neurologists and the pharmaceutical industry in Japan

This study evaluated the size and fraction of non-research compensation to Japanese board-certified neurologists from the pharmaceutical industry between 2016 and 2020. We found that more than US$45 million were made to 59.2% of all neurologists over the five years. There was an increasing trend in the payments to the neurologists over time.

REVIEW ARTICLES

Open Access

Host–microbiota interaction during cancer progression from bulk to single-cell level

  • First Published: 28 January 2024
Host–microbiota interaction during cancer progression from bulk to single-cell level

Host–microbiota interactions play a critical role in cancer progression from bulk to single-cell level. Growing technologies focus on characterizing the host–microbiota interaction. Microbiota-derived metabolites and components and themselves affect the host immune response and the proliferation of cancer cells. Microbiota is emerging as the target for anticancer therapy.

RESEARCH ARTICLES

Open Access

Single-cell RNA sequencing reveals telocytes subsets of human lung

  • First Published: 12 February 2024
Single-cell RNA sequencing reveals telocytes subsets of human lung

• Cellular atlas in human lung diseases of COPD, NSCLC and SSC was draw to habor PDGFRα+ cells and analyzed its subtypes.

• CD34+PDGFRα+ telocytes in lung tissues of lung diseases had been elaborated.

• Telocytes might communicate with the cells types in the microenvironment by secreted vesicles.

• The key signals such as TIMP1-CD63, VIM-CD44 and et al. were elucidated in telocytes dominated communication.

SHORT COMMUNICATION

Open Access

INTEGRAL-ILCCO cohort data analysis revealed the association of clonal haematopoiesis with an increased risk of lung cancer

  • First Published: 13 February 2024
INTEGRAL-ILCCO cohort data analysis revealed the association of clonal haematopoiesis with an increased risk of lung cancer

(1) The presence of clonal haematopoiesis mutations is associated with increased risk of lung cancer after adjusting other risk factors.

(2) The association between clonal haematopoiesis and lung cancer is mainly driven by mutations with high variant allele frequency.

(3) The association between clonal haematopoiesis and lung cancer is further supported by a meta-analysis including three cohorts.

COMMENTARY

Open Access

Role of DNA methylation in cancer development and its clinical applications

  • First Published: 13 February 2024
Role of DNA methylation in cancer development and its clinical applications

This article highlights DNA methylation-based cancer development and its clinical significance in an early detection approach.

REVIEW ARTICLES

Open Access

The relationship between folic acid and nonalcoholic fatty liver disease

  • First Published: 13 February 2024
The relationship between folic acid and nonalcoholic fatty liver disease

1. The beneficial effects of FA on NAFLD might be the DNA methylation regulation of NAFL-related genes.

2. FA may reduce inflammation and ER stress in the liver through direct or indirect effects.

3. FA may improve NAFLD by enhance the tight junction and reduce intestinal inflammation.

Open Access

CRISPR-based gene therapy for wet age-related macular degeneration in mouse model

  • First Published: 23 February 2024
CRISPR-based gene therapy for wet age-related macular degeneration in mouse model

1. Ageing changes, environmental risk factors and genetic susceptibility are the risk factors in wet AMD progression.

2. VEGF plays a vital role in the formation of CNV, the hallmark of wet AMD.

3. To avoid the need for long-term injections of anti-VEGF agents, CRISPR-based gene editing therapy shows great potential to treat wet AMD permanently.

4. Different targets involved in VEGF-related pathway(Hif-1α, VEGF and VEGFR)showed significant differences in the efficacy and targeting VEGFA at the appropriate time is an effective intervention strategy.